The impact of the epigenetic writer LSD1 in the cell cycle control in liver fibrosis and hepatocellular carcinoma

被引：1
|
作者：
Wang, L. [1 ]
Yu, X. [1 ]
Schmiel, M. [1 ]
Steinheuer, L. [1 ]
Eischeid, H. [1 ]
Ulmer, B. [1 ]
Buettner, R. [1 ]
Odenthal, M. [1 ]
机构：
[1] Univ Hosp Cologne, Pathol, Cologne, Germany
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
10.1016/S0168-8278(18)31640-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-188
引用
收藏
页码：S690 / S690
页数：1
相关论文
共 50 条
  • [1] LSD1 stimulates cell survival and epigenetic homeostasis via snail in hepatocellular carcinoma
    Jo, Yong Hwa
    Minh Nam Nguyen
    Choi, Tae Gyu
    Kim, Sung Soo
    CANCER RESEARCH, 2017, 77
  • [2] Deregulation of the histone demethylase LSD1 is involved in hepatocellular carcinoma
    Kim, Sangchul
    Kaneko, Syuzo
    Hayami, Shinya
    Yamaue, Hiroki
    Hamamoto, Ryuji
    CANCER SCIENCE, 2018, 109 : 1247 - 1247
  • [3] Over-expression of LSD1 promotes proliferation in hepatocellular carcinoma
    Lei, Zengjie
    Wang, Bin
    Chen, Dongfen
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 785 - 785
  • [4] Overexpression of LSD1 in hepatocellular carcinoma: a latent target for the diagnosis and therapy of hepatoma
    Zhao, Ze-Kun
    Dong, Ping
    Gu, Jun
    Chen, Lei
    Zhuang, Ming
    Lu, Wen-Jie
    Wang, Dao-Rong
    Liu, Ying-Bin
    TUMOR BIOLOGY, 2013, 34 (01) : 173 - 180
  • [5] LSD1 inhibition induces differentiation and cell death in Merkel cell carcinoma
    Leiendecker, Lukas
    Jung, Pauline S.
    Krecioch, Izabela
    Neumann, Tobias
    Schleiffer, Alexander
    Mechtler, Karl
    Wiesner, Thomas
    Obenauf, Anna C.
    EMBO MOLECULAR MEDICINE, 2020, 12 (11)
  • [6] LSD1: a viable therapeutic target in cutaneous squamous cell carcinoma?
    Egolf, Shaun
    Capell, Brian C.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (07) : 671 - 678
  • [7] Lysine Demethylase LSD1 Coordinates Glycolytic and Mitochondrial Metabolism in Hepatocellular Carcinoma Cells
    Sakamoto, Akihisa
    Hino, Shinjiro
    Nagaoka, Katsuya
    Anan, Kotaro
    Takase, Ryuta
    Matsumori, Haruka
    Ojima, Hidenori
    Kanai, Yae
    Arita, Kazunori
    Nakao, Mitsuyoshi
    CANCER RESEARCH, 2015, 75 (07) : 1445 - 1456
  • [8] Suppression of LSD1 enhances the cytotoxic and apoptotic effects of regorafenib in hepatocellular carcinoma cells
    Wu, Lin-wen
    Zhou, Dong-mei
    Zhang, Zuo-yan
    Zhang, Jian-kang
    Zhu, Hua-jian
    Lin, Neng-ming
    Zhang, Chong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 512 (04) : 852 - 858
  • [9] The Role Of Lsd1/kdm1 Isoform Lsd1+8a In Small Cell Lung Carcinoma
    Ihara, H.
    Tajima, K.
    Yagishita, S.
    Jotatsu, T.
    Hidayat, M.
    Wirawan, A.
    Ko, R.
    Kanemaru, R.
    Kato, M.
    Hayakawa, D.
    Shimada, N.
    Takahashi, F.
    Takahashi, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [10] LSD1 Inhibitor and Cisplatin Combination Treatment of Sinonasal Squamous Cell Carcinoma Cell Lines
    Weatherford, L.
    Kuhnell, D.
    Palackdharry, S.
    Vachon, R.
    Takiar, V.
    Langevin, S.
    Wise-Draper, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1189 - 1189
12345